The Handoff: Your Week in Neurology News - 12/8/16

Share this content:

The Handoff is a weekly roundup of neurology news covering various developments in subspecialties, the pharmaceutical industry, and the overall state of health care as it affects neurologists.

— Alzheimer's-related deaths are being blamed in part for the alarming decrease in life expectancy reported by the National Center for Health Statistics. 

— The 21st Century Cures Act is being hailed as a significant boost for mental health, as it is the first law requiring equal insurance coverage of both mental and physical health. 

— Strobe lighting may be a potential target for non-invasive therapy for Alzheimer's disease, according to results from a mouse study published in Nature

— Ethnic bias is prevalent in the neurology field, but some specialists are trying to change that.

— BBC broadcaster Andrew Marr is crossing the pond to undergo a controversial treatment that he hopes will address his disabilities after suffering a stroke.  

— Pfizer was hit with a $106 million fine from British regulators for hiking the price of phenytoin capsules nearly 2600%.

— Anavex Life Sciences reported positive results from their Phase 2a study of a drug that targets cellular homeostasis in Alzheimer's disease. 

— Artificial intelligence may help to uncover a new treatment of ALS. 

— The National Institutes of Neurological Disorders and Stroke used state of the art imaging technology to visualize what happens to the brain during cerebral malaria. Watch the video below. 

You must be a registered member of Neurology Advisor to post a comment.

Sign Up for Free e-newsletters

CME Focus